13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Sport Related Concussion and Spine Injury
Sport related concussions and spine injuries pose significant risks to athletes. A concussion, resulting from head or body impact, leads to temporary brain function impairment, with symptoms like headache, dizziness, and cognitive changes. Timely evaluation and management are crucial for safe return to play. Meanwhile, spine injuries, ranging from strains to severe fractures and spinal cord damage, occur due to sudden impact or repetitive stress during athletic pursuits. Immediate recognition, immobilization, and medical care are vital to prevent worsening and long-term disability. Preventive measures encompass proper technique training, protective gear usage, adherence to safety protocols, and educational initiatives targeting coaches, athletes, and parents for early detection and intervention. In essence, spinal health and sports safety demand comprehensive assessment, accurate diagnosis, and appropriate management for optimal outcomes and long-term well-being.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States